Clinical Trials Browser

NCT01962636 2026-03-12

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Leukemia, Plasma Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Clinical Trials

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Discontinuation Study

PREHAB-APA

CART I5M

MOTIVATE

DISCOVERY

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Myfall

SURGE

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

A Dietary Study for People With Multiple Myeloma

LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma

Randomised Controlled Trial of Artificial Intelligence-assisted Health Education

Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

Onco-ICOPE

POSBIO-CRC

EPC-MM+L

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Universal CAR-T Cell Therapy for MM

e-Motion : Promoting Emotion Regulation in Chronic Cancer

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

ProApix

ALHERT

BTP

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

PROACTIVE

Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid

Mosaic

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

ECAR01

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

ResisTec

VESICOM

CARTIER

A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

Risk Stratification and MRD-driven Maintenance for MM After ASCT

PALS_CT

Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

PEACE

Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies